BRAF c.334T>G ;(p.S112A)

Variant ID: 7-140534579-A-C

NM_004333.4(BRAF):c.334T>G;(p.S112A)

This variant was identified in 4 publications

View GRCh38 version.




Publications:


PepNN: a deep attention model for the identification of peptide binding sites.

Communications Biology
Abdin, Osama O; Nim, Satra S; Wen, Han H; Kim, Philip M PM
Publication Date: 2022-05-26

Variant appearance in text: BRAF: S112A
PubMed Link: 35618814
Variant Present in the following documents:
  • 42003_2022_3445_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page



Synergistic effects of SHP2 and PI3K pathway inhibitors in GAB2-overexpressing ovarian cancer.

American Journal Of Cancer Research
Sun, Bowen B; Jensen, Nathaniel R NR; Chung, Dongjun D; Yang, Meixiang M; LaRue, Amanda C AC; Cheung, Hiu Wing HW; Wang, Qi Q
Publication Date: 2019

Variant appearance in text: BRAF: S112A
PubMed Link: 30755818
Variant Present in the following documents:
  • Main text
View BVdb publication page



Control of cell death and mitochondrial fission by ERK1/2 MAP kinase signalling.

The Febs Journal
Cook, Simon J SJ; Stuart, Kate K; Gilley, Rebecca R; Sale, Matthew J MJ
Publication Date: 2017-12

Variant appearance in text: BRAF: Ser112Ala
PubMed Link: 28548464
Variant Present in the following documents:
  • Main text
  • FEBS-284-4177.pdf
View BVdb publication page



p21-Activated kinase 1 (Pak1) phosphorylates BAD directly at serine 111 in vitro and indirectly through Raf-1 at serine 112.

Plos One
Ye, Diana Z DZ; Jin, Shenghao S; Zhuo, Ya Y; Field, Jeffrey J
Publication Date: 2011

Variant appearance in text: BRAF: S112A
PubMed Link: 22096607
Variant Present in the following documents:
  • pone.0027637.pdf
View BVdb publication page